Skip to main content
Industry News
FDA may authorize convalescent plasma for COVID-19

The FDA could soon authorize emergency use of blood plasma collected from people who have recovered from COVID-19 to treat newly sickened patients, according to sources. The decision could be issued as early as next week, the sources said.

Full Story: